Participate in clinical research
For drugs and therapies to be developed for PKD, clinical studies must be conducted.
Basic research and studies
Basic research to understand PKD is the foundation that all therapy development is based on. Learn about key discoveries and the ongoing effort to find a treatment and cure for PKD.
PKD Foundation research grants program – 2016 project summaries
To support work being done to find treatments and a cure, we have awarded 15 research grants to PKD researchers.
PKD clinical studies fast draw
Learn about the different types of studies and how you can help advance PKD research.
A closer look at clinical studies
Our Chief Scientific Officer talks about the clinical study process including how clinical studies are designed and how enrollment decisions are made. Originally aired: July 2016
PKD Foundation research grants program – 2014 project summaries
To support work being done to find treatments and a cure, we have awarded 15 research grants to PKD researchers. We will spend nearly $2.4 million over the next two years (2014-16) on these grants.
Conversation with a researcher
Bradley Yoder, Ph.D., discusses the results of his recently completed PKD Foundation-funded project “In vivo analysis of cilia mechanosensation in the kidney.”
Drug repurposing
Drug repurposing is the process of developing new uses for existing drugs or drug candidates. This takes advantage of work that has been done for a different treatment use, thereby decreasing development costs and time to launch.
Tissue donation
Our tissue donation program provides patients with an avenue to contribute to the advancement of our understanding of PKD. We coordinate donations of discarded PKD kidneys to research labs across the country.
Milestones in PKD research
Follow the timeline of research accomplishments due to PKD Foundation funding and involvement.
Clinical studies: Patient participation is key in developing treatments
Without participation in research, medical breakthroughs cannot happen and new therapies cannot be approved for patient use.
The sequence of drug development
Hear from PKD Foundation Chief Scientific Officer David Baron, Ph.D. as he uses his decades of experience in drug development to explain the process as it relates to PKD.
Chief Scientific Officer webinar
Hear from our new Chief Scientific Officer David Baron, Ph.D., who is also a PKD patient.
Know when
change happens
This is such an exciting time for PKD science! Advancements in PKD research are bountiful and we have the scoop to keep you up to date.